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Abstract
Background: Because of the implant-related problems with pedicle screw-based spinal instrumentations, other
types of fixation have been tried in spinal arthrodesis. One such technique is the direct trans-pedicular, trans-discal
screw fixation, pioneered by Grob for spondylolisthesis. The newly developed GO-LIF procedure expands the scope
of the Grob technique in several important ways and adds security by means of robotic-assisted navigation. This is
the first clinical trial on the GO-LIF procedure and it will assess safety and efficacy.
Methods/Design: Multicentric prospective study with n = 40 patients to undergo single level instrumented spinal
arthrodesis of the lumbar or the lumbosacral spine, based on a diagnosis of: painful disc degeneration, painful
erosive osteochondrosis, segmental instability, recurrent disc herniation, spinal canal stenosis or foraminal stenosis.
The primary target criteria with regards to safety are: The number, severity and cause of intra- and perioperative
complications. The number of significant penetrations of the cortical layer of the vertebral body by the implant as
recognized on postoperative CT. The primary target parameters with regards to feasibility are: Performance of the
procedure according to the preoperative plan. The planned follow-up is 12 months and the following scores will
be evaluated as secondary target parameters with regards to clinical improvement: VAS back pain, VAS leg pain,
Oswestry Disability Index, short form - 12 health questionnaire and the Swiss spinal stenosis questionnaire for
patients with spinal claudication. The secondary parameters with regards to construct stability are visible fusion or
lack thereof and signs of implant loosening, implant migration or pseudarthrosis on plain and functional
radiographs.
Discussion: This trial will for the first time assess the safety and efficacy of guided oblique lumbar interbody
fusion. There is no control group, but the results, the outcome and the rate of any complications will be analyzed
on the background of the literature on instrumented spinal fusion. Despite its limitations, we expect that this study
will serve as the key step in deciding whether a direct comparative trial with another fusion technique is
warranted.
Trial Registration: Clinical Trials NCT00810433
Background
For many degenerative, inflammatory and traumatic
conditions of the spine as well as for spinal deformities,
the definitive fusion of one or several spinal motion seg-
ments (spinal arthrodesis) remains the treatment of
choice at this time. Fusion requires the preparation of a
fusion mass between two vertebrae or their posterior
elements and adequate stability for the period of time
that is required to achieve solid bony bridging. While
t h e r ea r ean u m b e ro fd i f f e r e n tf u s i o nt e c h n i q u e s ,t h e
necessary stabilization is currently almost exclusively
achieved by pedicle screw - rod - systems. This techni-
que requires 2 pedicle screws to be placed into each ver-
tebra, which for a single-level fusion translates to 4
screws and 2 interconnecting rods. Since for every indi-
vidual screw placement there is an inherent risk of
implant malpositioning and nerve injury, this particular
risk is encountered 4 times in a typical single-level
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implant-related complication rates for lumbar or lumbo-
sacral spinal fusion surgery are reported as high as 19
percent [1,2]. On the background of such complication
rates and also on the basis of biomechanical considera-
tions [3], alternative trans-pedicular trans-discal fixation
techniques have been tried. Such trajectories had already
been used in combination with pedicle screw and/or
transvertebral cage constructs for high dysplastic spon-
dylolistheses [4-10]. Grob and recently Zagra (using the
Grob technique) were the first to use 2 trans-pedicular,
trans-discal screws alone to stabilize a lumbar or lumbo-
sacral motion segment for posterolateral fusion [11,12].
While in theory this technique reduces the risk of screw
misplacement and hence of nerve injury by 50 percent
per fused motion segment, they still experienced some
implant-related complications requiring revision surgery.
These implant misplacements were judged to be due to
the difficulty of drilling the anatomically demanding
screw trajectories under fluoroscopic control alone. The
“Guided Oblique Lumbar Interbody Fusion” (GO-LIF)
procedure overcomes these problems by means of
robotic-assisted computer navigation, whose accuracy
has been established [13-15]. It also expands on the ori-
ginal Grob procedure in 3 important ways: First, it
makes minimally invasive, percutaneous screw place-
ment possible. Second, it allows for the combination
with intervertebral cage fusion techniques. And third, it
doesn’t require the presence of spondylolisthesis. These
3 factors greatly expand the range of possible indica-
tions. However, with less than 20 cases having been per-
formed worldwide, it cannot yet be known whether
GO-LIF might in the future represent a valid alternative
to pedicle screw-based stabilization techniques. This
clinical trial was designed to examine the safety and the
efficacy of the GO-LIF procedure.
Methods/Design
This is a multicentric cases series that will be compared
to literature control. The study design has been
reviewed and approved by the ethics committee of the
Ludwig-Maximilian-University of Munich, Germany. A
participant insurance policy has been provided and the
trial has been registered at http://www.clinicaltrials.gov
[16]. The main author is responsible for the study
design, for monitoring the data collection and the anon-
ymization as well as for the data analysis. Independent
experts in spinal surgery with no association to the GO-
LIF procedure or the study have committed to evaluate
and judge adverse events, should any occur. These
experts would then report to the ethics committee as
well as to the study leaders. There are 10 participating
centers in Germany, Switzerland and Italy, where a total
of 40 patients are to be recruited within 6 months. We
plan to present descriptive statistics and to discuss the
findings on the background of the published literature.
Included will be men and women between 18 and 80
years of age, capable of giving informed consent and
with a clear clinical indication for monosegmental lum-
bar or lumbosacral fusion (with or without decompres-
sion) based on a diagnosis of at least one item in the
following list:
￿ painful disc degeneration (black disc)
￿ painful erosive osteochondrosis
￿ segmental instability
￿ recurrent disc herniation
￿ spinal canal stenosis
￿ foraminal stenosis
Exclusion Criteria are:
1) Lumbar hyperlordosis >70° between the end plate
of the lumbar vertebral body 1 and the end plate of the
sacral vertebral body 1 (because of the risk of injury to
the facet joint below the instrumented level).
2) Deformities of the vertebral bodies envisioned for
instrumentation (or the sacrum).
3) Spondylolisthesis >grade 2 (Meyerding).
4) Scoliosis and other deformities in the coronal plane
(not asymmetric disc space collapse).
5) Fractures of the vertebrae envisioned for
instrumentation.
6) Osteoporosis or osteopenia (known diagnosis or as
assessed by DXA or qCT).
7) Therapy with systemic corticosteroids or
immunosuppressants.
8) Metabolic bone diseases, such as osteomalacia or
Paget’s disease.
9) Post inflammatory instability of the vertebral spine.
10) Status post radiation therapy of the relevant spinal
region.
11) Current Coumadin (or Warfarin) or Heparin ther-
apy for more than 6 months at the time of operation.
12) Malignant diseases with or without bone
metastases.
13) Immunologic-inflammatory diseases (e.g. rheuma-
toid arthritis).
14) Diabetes mellitus.
15) ongoing infectious conditions.
16) body mass index (BMI) >30.
Operative Technique
The preoperative CT scan will be used for planning and
navigation. In surgery, the SpineAssist miniature robotic
device will be attached to the operating table and to the
patient by means of a special bed frame and a Kirschner
wire, which is anchored in a spinous process superior to
the segment to be operated on (figure 1). After referen-
cing and matching of the operative situation to the pre-
operative plan by means of 2 fluoroscopy images, the
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device to the correct position. The miniature robotic
device will then be fitted with one of three available
arms (as prompted by the workstation), which carries a
drill sleeve at its end. A support arm that is fixed to the
bed mount will give additional stability so that the
implant trajectory will be drilled in exactly the way it
was planned (figure 2). If decompression is required, it
will be performed according to microsurgical standard.
In cases with a completely collapsed disc space, no
interbody device is required and only bone graft may be
used to fill the residual disc space if there is any. In
every other case, an interbody fusion will be performed
according to the surgical standards of a PLIF or TLIF
procedure. Finally, the GO-LIF screw implants are
placed and the procedure is ended (example shown in
figure 3). While the example shown is a GO-LIF fixation
at the L5/S1 level, GO-LIF can be performed at all lum-
bar levels. The GO-LIF fixation is not suited for spondy-
lolisthesis reduction, which means that it can only be
applied in situations of a spondylolisthesis where an in-
situ fixation and fusion is planned.
The imaging modalities to be used in this study are
plain radiographs and computed tomography (CT). The
pre-operative CT, which is required to define the surgi-
cal anatomy, will be saved in such a way that it can also
be used for the preoperative planning and the intrao-
perative navigation. A routine postoperative CT of the
instrumented vertebrae will be acquired to evaluate
implant positioning and to exclude intraspinal bleeding.
This scan will also be used to compare the planned
position of the GO-LIF implants to their real position
and hence serve as a parameter for the safety of the pro-
cedure. Any implant deviations from the planned posi-
tion will be measured and categorized in 1 millimeters
increments. This data will be presented and discussed in
full. Implants penetrating the pedicular or the vertebral
cortex by more than 4 millimeters will be categorized as
Figure 1 The SpineAssist miniature robotic device is mounted
on a radiolucent frame, which is attached to the patient. One
of the modular arms (arm #2 in this case) is attached to the
miniature robotic device and carries the drill sleeve at its end. A
Steinmann pin is manually passed through the drill sleeve for
demonstration purposes.
Figure 2 Shows the percutaneous drilling of a GO-LIF screw trajectory, using the drill sleeve. Lateral fluoroscopy is used to control for
depth.
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and Robbins [17]. Such implants will be considered
unsafe in the sense of the target criterion. The plain
radiographs will be used to assess construct stability,
implant position, implant migration or loosening, forma-
tion of a sold fusion mass or indication of
pseudarthrosis.
The following clinical data/scores will be evaluated:
￿ Current pre-operative analgesic treatment
￿ Visual Analog Scale for back pain (VAS back)
￿ Visual Analog Scale for leg pain (VAS leg)
￿ Oswestry Disability Index (ODI)
￿ Short Form - 36 health questionnaire (SF-36)
￿ Swiss Spinal Stenosis Questionnaire (SSS)
Data will be collected at the following measurement
points:
1) Immediately preoperatively.
2) Intra- or perioperatively.
3) 6 weeks postoperatively.
4) 3 months postoperatively.
5) 6 months postoperatively.
6) 12 months postoperatively.
7) Thereafter, annually if after the completion of the
proposed study, an extension of the follow-up period is
applied for and approved.
The primary target parameters (to be assessed within
the immediate perioperative phase) with regards to
safety are:
￿ Number, severity, and cause of intra- and periopera-
tive complications, in particular injury or irritation of
nerve roots.
￿ Number of significant (>4 mm) penetrations of the
cortical layer of the vertebral body or the pedicle by the
implant, as recognized on a postoperative CT.
The primary target parameter with regards to feasibil-
ity (to be assessed within the immediate perioperative
phase) is:
￿ Feasibility is defined as performing the intervention
according to the preoperative plan. The number of
interventions that could not be performed according to
plan as well as the cause thereof serve as feasibility
indicators.
The secondary target parameter with regards to con-
struct stability (to be assessed on all follow-up visits
until 12 months) is:
￿ In order to assess the stability of the GO-LIF fixa-
tion, the routinely performed functional radiographs
after fixation operations will be evaluated.
The secondary target criteria with regards to clinical
improvement (to be assessed on all follow-up visits until
12 months) are:
￿ VAS for back and leg pain, ODI and SF-36 health
questionnaire and the SSS questionnaire.
We performed a power analysis in order to assess the
r e q u i r e ds a m p l es i z et os h o ws a f e t yw i t hap o w e r( 1 - b)
of 0.8 and an a of 0.05. As basis for our calculation, we
used the rates (5%-trimmed mean and standard devia-
tion) of correctly placed pedicle screw implants in the
best meta analysis available for such a purpose [18].
With an effect size (d) of 0.4478528 and an actual
power (1-b) of 0.808629, the total sample size calculated
as n = 33. Leaving some room for additional power
Figure 3 3-D-reconstruction of a percutaneous in-situ fixation of a grade 2 isthmic spondylolisthesis at L5/S1 using the GO-LIF
technique.
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result of protocol violations, we decided upon n = 40 as
the number of patients to be recruited.
Discussion
This is a clinical case series without a direct control and
hence without randomization, which brings certain lim-
itations to our study. Our choice of study design was
influenced by several considerations. For one, since this
is the “phase 1” clinical study on a new fixation techni-
que and therefore safety and efficacy are the primary
parameters to be studied, we are at this point not pri-
marily interested in showing superiority or non-inferior-
ity of the GO-LIF technique as compared to any other
established fusion technique. It would have therefore
not strengthened this first study to include another
fusion technique as a comparison. This even more so, as
there is no universally accepted fusion technique that
everyone would agree on as the gold standard against
which to compare a new technique. The power calcula-
tion for this study was rendered difficult by the follow-
ing factors. On the background of the very
inhomogeneous literature on spinal fusion surgery and
since we expect none or few neurological complications
with the use of navigation, this parameter would not
have been suitable for use in our power analysis. In view
of our primary target criteria, we therefore had to use a
technical parameter, in this case, the accuracy of screw
placement. With various classifications and with the
inconstant reporting of complications in clinical trials,
we resorted to the data collected and evaluated by Kos-
mopoulos et al. as the basis for our power calculation
[18]. Even though the number of patients to be included
resulted from a power analysis, it should be remembered
that based on Hanley’s “rule of three”, even if no adverse
events are to occur it cannot be concluded that such
events will not happen in future patients undergoing the
same procedure [19]. Depending on the outcome of this
study, a prospective and randomized trial comparing
GO-LIF to another fusion technique will be the next
step.
Abbreviations
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